Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.
DiMartino SJ, Mei J, Schnitzer TJ, Gao H, Eng S, Winslow C, Ho T, Turner KC, Hassan HE, Patel Y, Davis JD, Trinh N, Manley A, Manvelian G, Fetell M, Braunstein N, Geba GP, Dakin P. DiMartino SJ, et al. Among authors: fetell m. Osteoarthr Cartil Open. 2024 Oct 22;6(4):100533. doi: 10.1016/j.ocarto.2024.100533. eCollection 2024 Dec. Osteoarthr Cartil Open. 2024. PMID: 39554479 Free PMC article.
Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.
Baakman AC, Zuiker R, van Gerven JMA, Gross N, Yang R, Fetell M, Gershon A, Gilgun-Sherki Y, Hellriegel E, Spiegelstein O. Baakman AC, et al. Among authors: fetell m. Br J Clin Pharmacol. 2019 May;85(5):970-985. doi: 10.1111/bcp.13885. Epub 2019 Mar 14. Br J Clin Pharmacol. 2019. PMID: 30710391 Free PMC article. Clinical Trial.
Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W Genotype.
Price N, Namdari R, Neville J, Proctor KJ, Kaber S, Vest J, Fetell M, Malamut R, Sherrington RP, Pimstone SN, Goldberg YP. Price N, et al. Among authors: fetell m. Clin J Pain. 2017 Apr;33(4):310-318. doi: 10.1097/AJP.0000000000000408. Clin J Pain. 2017. PMID: 28266963 Free PMC article. Clinical Trial.
Metastases to the pineal gland.
Lassman AB, Bruce JN, Fetell MR. Lassman AB, et al. Among authors: fetell mr. Neurology. 2006 Oct 10;67(7):1303-4. doi: 10.1212/01.wnl.0000238516.29603.33. Neurology. 2006. PMID: 17030775
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
Prados MD, Schold SC Jr, Fine HA, Jaeckle K, Hochberg F, Mechtler L, Fetell MR, Phuphanich S, Feun L, Janus TJ, Ford K, Graney W. Prados MD, et al. Among authors: fetell mr. Neuro Oncol. 2003 Apr;5(2):96-103. doi: 10.1093/neuonc/5.2.96. Neuro Oncol. 2003. PMID: 12672281 Free PMC article. Clinical Trial.
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: fetell m. J Neurooncol. 1999 Sep;44(2):155-62. doi: 10.1023/a:1006391619009. J Neurooncol. 1999. PMID: 10619499 Clinical Trial.
43 results